[Prevention of contrast nephropathy; guidelines from the Department Nephrology of the University Medical Centre Groningen].
Kramers
C
C
Wetzels
J
J
Natsch
S
S
ten Dam
M
M
D000111:Acetylcysteine / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001682:Biological Availability; D003287:Contrast Media / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009426:Netherlands; D015532:Rehydration Solutions / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000139:chemically induced / Q000517:prevention & control*; D012965:Sodium Chloride / Q000627:therapeutic use*
D003287:Contrast Media; D015532:Rehydration Solutions; D012965:Sodium Chloride; D000111:Acetylcysteine